First, we have provided direct evidence that ISL is a potent COX-2, mPGES-1 and CYP4A11 inhibitor, and thereby blocks angiogenesis and induces vascular normalization in glioma through downregulation of FGF-2, TGF-β and VEGF. Here, TGFB1 is linked to central nervous system cancer.